US Biotechs Eye KOSDAQ Listings on Strength of Tech Export Deals
US biotech ventures Ingenia, BreezeBio, Pinetree, and Kaijin are pursuing KOSDAQ listings, drawn by higher valuations from tech export deals and lower costs than NASDAQ.
Read the full article1d agoen
You might also wanna read
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
This could be a key move for future growth.
Bars·6d ago
SpaceX, OpenAI Windfall Fuels Bets on Next-Wave Asian AI Winners
📰 #Finance "The hunt is on for companies that could benefit from the tailwinds of an unprecedented wave of stock offerings in the US, and i
bloomberg.com·1mo ago
Basel Area Business & Innovation partners with Korean biopharma firms Roche Korea, KHIDI, and KIBO
Basel Area Business & Innovation inks new collaboration with Korean biopharma companies
biospectrumasia.com·1mo agoWhile SpaceX Gets the Headlines, Smart Investors Are Loading Up on This Stock Instead
This big biotech stock doesn't get the hype that SpaceX does. But it could be the smarter bet right now.
Bars·5d ago
Orchid CEO Noor Siddiqui on genetic embryo screening, controversy, and 'stacking the deck' for healthier babies
The category creator in reproductive health talks 'superbabies,' Thiel Fellows and startup 'holy wars' on the Upstarts Podcast.
upstartsmedia.com·1mo ago
Recent moves of note in and around the biotech and pharma industries
Recent moves of note in and around the biotech and pharma industries
nature.com·14d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.